Top Markets
Coin of the day
TCM Biotech International Corp. TCM Biotech International Corp.

TCM Biotech International Corp.

4169
Classifica tra le azioni #15798
TCM Biotech International Corp., a biotech company, engages in the research and... TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Prezzo delle azioni
$4.96
Capitalizzazione di mercato
$329.54M
Variazione (1 giorno)
2.63%
Variazione (1 anno)
53.49%
Paese
TW
Scambia TCM Biotech International Corp. (4169)

Categoria

Rapporto P/S per TCM Biotech International Corp. (4169)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di TCM Biotech International Corp., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per TCM Biotech International Corp. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
10.95 -
US
12.19 -
NL
24.99 -
US
3.75 -
AU
- -
CH